Radius Health, Inc. Business Operations Contracts & Agreements
33 Contracts & Agreements
- Development Agreements (5 contracts)
- Indemnification Agreements (2)
- Sales Agreements (5)
- Services Agreements (15)
- Supply Agreements (6)
- Commercial Supply Agreement, dated June 28, 2016, between the Company and Vetter Pharma International GmbH (Filed With SEC on August 5, 2021)
- Amendment No. 1, dated December 1, 2019, to Commercial Supply Agreement, dated June 28, 2016, between the Company and Vetter Pharma International GmbH (Filed With SEC on February 27, 2020)
- Amendment No. 2, dated June 10, 2019, to the Manufacturing Services Agreement, dated July 13, 2016, between the Company and Polypeptide Laboratories Holding (PPL) AB, as successor... (Filed With SEC on August 7, 2019)
- Amendment No. 2, dated June 18, 2019, to Supply Agreement, dated June 23, 2016, between the Company and Ypsomed AG (Filed With SEC on August 7, 2019)
- Amendment No. 1, dated February 7, 2017, to the Supply Agreement, dated June 23, 2016, between the Company and Ypsomed AG (Filed With SEC on August 7, 2019)
- Amendment No. 1 to Manufacturing Services Agreement, dated July 13, 2016, between the Company and Polypeptide Laboratories Holding (PPL) AB, as successor to Lonza Sales Ltd (Filed With SEC on May 8, 2019)
- Form of Indemnification Agreement between the Company and its Officers (Filed With SEC on February 28, 2019)
- Form of Indemnification Agreement between the Company and its Directors (Filed With SEC on February 28, 2019)
- Scale-Up and Commercial Supply Agreement, dated February 27, 2018, between the Company, 3M Company and 3M Innovative Properties Company (Filed With SEC on May 10, 2018)
- Manufacturing Services Agreement (the Agreement) (Filed With SEC on November 3, 2016)
- SUPPLY AGREEMENT effective as of September 30, 2015 ("Effective Date") between (Filed With SEC on August 4, 2016)
- AMENDMENT NO. 4 TO DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT (Filed With SEC on May 5, 2016)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Statement of Work To the Agreement between RADIUS HEALTH, INC. (RADIUS) and LONZA Sales AG dated 16 of... (Filed With SEC on May 5, 2016)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Statement of Work To the Agreement between RADIUS HEALTH, INC. (RADIUS) and LONZA Sales AG dated 16 of... (Filed With SEC on May 5, 2016)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Statement of Work To the Agreement between RADIUS HEALTH, INC. (RADIUS) and LONZA Sales AG dated 16 of... (Filed With SEC on May 5, 2016)
- AMENDMENT NO. 3 TO DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT (Filed With SEC on February 25, 2016)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 5 TO WORK STATEMENT NB-3 (Filed With SEC on February 25, 2016)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 4 TO WORK STATEMENT NB-3 (Filed With SEC on February 25, 2016)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 8 TO WORK STATEMENT NB-1 (Filed With SEC on February 25, 2016)
- AMENDMENT N6 TO PHARMACEUTICAL DEVELOPMENT AGREEMENT (Filed With SEC on November 5, 2015)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 3 (Filed With SEC on August 6, 2015)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 9 TO WORK STATEMENT NB-1 (Filed With SEC on May 6, 2015)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 7 TO WORK STATEMENT NB-1 (Filed With SEC on August 12, 2014)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 6 TO WORK STATEMENT NB-1 (Filed With SEC on August 12, 2014)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 5 TO WORK STATEMENT NB-1 (Filed With SEC on May 20, 2014)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 4 TO WORK STATEMENT NB-1 (Filed With SEC on April 1, 2014)
- AMENDMENT NO. 2 TO DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT (Filed With SEC on February 11, 2014)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 3 TO WORK STATEMENT NB-1 (Filed With SEC on November 14, 2013)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 1 TO WORK STATEMENT NB-2 (Filed With SEC on November 14, 2013)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 2 TO WORK STATEMENT NB-1 (Filed With SEC on June 22, 2012)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240.24b-2 CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 1 TO WORK STATEMENT NB-1 (Filed With SEC on December 15, 2011)
- AMENDMENT N2 TO PHARMACEUTICAL DEVELOPMENT* AGREEMENT (Filed With SEC on November 9, 2011)
- CLINICAL TRIAL SERVICES AGREEMENT* (Filed With SEC on May 23, 2011)
